Portfolio company
Treefrog Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a stem cell production platform to provide regenerative medicine therapies for pharmaceutical firms and patients with neurodegenerative diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
Cellino Bio
This company develops an autonomous biomanufacturing platform that uses artificial intelligence and lasers to produce personalised cell therapies for patients with degenerative diseases.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Neuroplast
This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Stem Pharm
This company develops human neural organoids and synthetic biomaterials for pharmaceutical partners to model neurological diseases and screen drug candidates.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
